Market News AIOpen the app

TScan Therapeutics announced that two directors are leaving and new ones are joining the team.

New bossRead the original at SEC EDGAR
Neutral

Two directors left, and the filing lists members of the governance and audit committees. It says neither departure involved disagreement with TScan and reports no change to the company's work or plans.

TCRX · TScan Therapeutics, Inc.

AI read · Neutral

The AI's read

The filing says neither departure followed a disagreement about TScan's operations, practices, or policies. It also lists members of the governance and audit committees. The report describes no change to TScan's work or plans, so these board changes do not point clearly toward a better or worse business outlook.

Get alerts for TCRX

Follow TScan Therapeutics, Inc. (TCRX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TCRX
Free on the App Store and Google Play, or on the web.